Tod R. Hamachek

Tod Hamachek was named chairman and chief executive officer of Penwest Pharmaceuticals Co. in October 1997 and retired from Penwest in 2005. Prior to the spin-off of Penwest Pharmaceuticals from Penford Corporation, Ltd., Tod was president and chief executive officer of Penford. Previously, he was senior vice president of the manufacturing group of Univar Corporation, Penwest's parent at that time. Penwest was spun off from Univar in 1984.

He is past director of First Interstate Bank of Washington and DEKALB Genetics Corporation; past director of The Washington Roundtable; past chairman and member of the advisory board of The University of Washington School of Business; past vice chairman and trustee of The Seattle Foundation; past trustee of Williams College and Lewis & Clark College, the Nature Conservancy – Washington Chapter, Pacific Science Center, and the Pacific Northwest Arts and Crafts Association; past chairman of the board of trustees of The Pacific Crest Outward Bound School; and past trustee of Outward Bound, Inc., and a past trustee of the Aldrich Museum of Contemporary Art, Ridgefield, Conn.

He is chairman of the board of directors for Northwest Natural Gas Company, member of the board at The Seattle Times Co. and the Blethen Corporation (majority owner of The Seattle Times), a member and chair of the Virginia Mason Health System and Virginia Mason Medical Center boards and a member and past chair of the Sun Valley Center for the Arts.

Hamachek earned his bachelor's degree from Williams College and a MBA from Harvard Business School.